NuProbe Revenue and Competitors

Houston, TX USA

Location

$53M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NuProbe's estimated annual revenue is currently $3.3M per year.(i)
  • NuProbe's estimated revenue per employee is $77,500
  • NuProbe's total funding is $53M.

Employee Data

  • NuProbe has 43 Employees.(i)
  • NuProbe grew their employee count by -51% last year.

NuProbe's People

NameTitleEmail/Phone
1
CEO and ChairmanReveal Email/Phone
2
Ex VP, Scientific Research ServiceReveal Email/Phone
3
VP ManufacturingReveal Email/Phone
4
VP R&DReveal Email/Phone
5
Co-Founder and DirectorReveal Email/Phone
6
Associate Director FinanceReveal Email/Phone
7
Associate Director InnovationReveal Email/Phone
8
Director OperationsReveal Email/Phone
9
Senior Laboratory ManagerReveal Email/Phone
10
Scientist IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M1344%N/AN/A
#2
$14.9M73-8%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M5-37%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M5131%N/AN/A
#8
$0.8M525%N/AN/A
#9
$1.6M913%N/AN/A
#10
$16.3M80-9%N/AN/A
Add Company

What Is NuProbe?

We accelerate technology innovation in precision diagnostics to enable diseases to be detected, treated and cured earlier for better outcomes with lower costs.

keywords:N/A

$53M

Total Funding

43

Number of Employees

$3.3M

Revenue (est)

-51%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NuProbe News

2022-04-17 - NuProbe Published Method for Designing Highly Multiplex ...

NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary molecular diagnostic technologies to improve the...

2022-04-06 - NuProbe QASeq Technology Enables Simultaneous ...

NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary molecular diagnostic technologies to improve the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.8M4310%$10M
#2
$5.8M43-2%N/A
#3
$5M43-14%N/A
#4
$4.6M4313%N/A
#5
$6.4M43-4%N/A